(VIANEWS) - Cronos Group (NASDAQ: CRON) stock prices increased 32% in just 21 sessions from August 10th until Monday at 11:25 EST at EUR2.31. This surge followed two straight sessions of gains on both ends and a subsequent jump by the NASDAQ index by 0.52% to EUR13,833.71 which also showed signs of strength. Cronos Group last closing price stood at EUR2.20 which was 39.16% below their 52-week high of EUR3.62--bearing witness to investors and analysts the potential for future gains!
About Cronos Group
Cronos Group Inc. is a cannabinoid company offering an assortment of hemp-derived supplements and cosmetic products through various channels in the United States, such as online retailing, hospitality partner channels, e-commerce sales channels, as well as e-commerce sales of its Lord Jones brand of hemp-derived supplements and cosmetics. Cronos also cultivates, manufactures, markets, sells and delivers cannabis and cannabis-derived products such as dried cannabis, pre-rolls, edibles, concentrates and extracts directly to clients via its wellness platform PEACE NATURALS while operating under adult-use brand Spinach. Established in 2012 and operating from Toronto Canada since then; Cronos Group has over 8 years experience operating successfully out of Canada under its Spinach adult-use brands - both of which operate under its PEACE NATURALS wellness platform PEACE NATURALS; operating under both brand Spinach brand as well as adult-use brand Spinach adult-use brands Spinach brand; since 2012.
Yearly Analysis
According to available data, Cronos Group's stock (CRO) is trading at EUR2.31, significantly below its 52-week high of EUR3.62 but significantly above its low point of EUR1.64. This indicates a significant decline during 2018, yet recent signs point towards its recovery. Cronos Group's sales growth projections suggest negative growth of 12.2% this year and positive growth of 20% for next year - suggesting some short-term challenges but an optimistic outlook for a comeback down the road. Cronos Group currently reports an EBITDA figure of -2.27, which indicates negative earnings prior to taking into account interest, taxes, depreciation and amortization expenses. This suggests the company is operating at a loss which may be concerning for some investors. Overall, Cronos Group appears to be promising, with expected sales growth within the year and current financial performance that remains uncertain. Before making investment decisions based on this information alone, investors should carefully assess these elements as well as any others that may come to light.
Technical Analysis
Cronos Group (CRON) stock has experienced volatile price swings recently, rising above both its 50-day moving average of EUR1.85 and 200-day moving average of EUR2.16. While this could signal an upward trend for CRON shares, investors should exercise caution as its volatility remains high. Today's trading volume for this stock was 67.23% above its average volume of 2103730; this could signal increased interest. Traders should however remain mindful of potential increased volatility caused by higher trading volumes. Cronos Group had average intraday variation averages over the past week, month and quarter that were 2.84%, 1.40% and 3.08%, with its highest amplitude being 4.34% (week), 3.90% (month) and 3.08% (quarter). Investors should keep these figures in mind to gauge stock volatility. According to the stochastic oscillator, which measures overbought and oversold conditions, Cronos Group stock appears to be oversold (=20), suggesting a potential buying opportunity for investors; however, further investigation should be conducted prior to making any definitive investment decisions. Overall, investors should keep a close watch on Cronos Group's stock performance and be ready for potential fluctuations in price. Conduct thorough research before making any investments decisions.
Quarter Analysis
Cronos Group's sales growth is negative for both current and subsequent quarters, showing a decrease of 19.1% and 8.9%, which should cause investors to be concerned that sales may be diminishing. Cronos Group estimates growth estimates for both their current quarter and the following one as being positive at 80% and 90.5%, suggesting they anticipate an improvement in sales growth soon. Noting the company's year-on-year quarterly revenue growth has declined 11.9% year-on-year for twelve trailing months totalling $86.11M is telling. It shows their revenues have been decreasing over this period. Given Cronos Group's negative sales growth and declining revenue projections, investors should exercise extreme caution before making an investment decision in its stock. Positive estimates for growth over the coming quarters may signal optimism about its performance and warrant keeping an eye on.
Equity Analysis
Based on the available information, Cronos Group currently has a negative trailing twelve month EPS of EUR-0.41. This indicates that they are not currently profitable. Furthermore, their return on equity for that period was negative -12.1% which suggests they are not offering investors an acceptable return for their equity invested by shareholders. Investors should carefully examine these financial metrics alongside other considerations, such as growth potential, competitive landscape and overall market conditions before making investment decisions. Past performance does not guarantee future outcomes. Before investing, investors should carefully evaluate Cronos Group's financial performance and other relevant factors before making their own investment decisions. It may be prudent to seek professional guidance before purchasing any stock.
More news about Cronos Group (CRON).